HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ina Weiner Selected Research

SSR180711

6/2009Pro-cognitive and antipsychotic efficacy of the alpha7 nicotinic partial agonist SSR180711 in pharmacological and neurodevelopmental latent inhibition models of schizophrenia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ina Weiner Research Topics

Disease

30Schizophrenia (Dementia Praecox)
01/2020 - 03/2003
9Psychotic Disorders (Schizoaffective Disorder)
01/2020 - 05/2007
4Neurobehavioral Manifestations
10/2011 - 06/2009
3Hypersensitivity (Allergy)
03/2012 - 12/2009
2Cognitive Dysfunction
10/2011 - 03/2009
2Infections
10/2003 - 09/2003
1Demyelinating Diseases (Demyelinating Disease)
01/2020
1Ischemia
01/2018
1Anhedonia
07/2017
1Virus Diseases (Viral Diseases)
01/2016
1Mental Disorders (Mental Disorder)
01/2016
1Neurodevelopmental Disorders
03/2012
1Weight Gain
05/2011
1Catalepsy
05/2011
1Shock
10/2010
1Schizotypal Personality Disorder
01/2009
1Huntington Disease (Huntington's Disease)
12/2003

Drug/Important Bio-Agent (IBA)

20Antipsychotic Agents (Antipsychotics)IBA
03/2012 - 09/2003
14Amphetamine (Amfetamine)FDA LinkGeneric
03/2012 - 03/2003
8Poly I-CIBA
01/2020 - 10/2003
5Pharmaceutical PreparationsIBA
10/2011 - 06/2009
4Estrogens (Estrogen)FDA Link
02/2012 - 11/2009
3Clozapine (Clozaril)FDA LinkGeneric
11/2011 - 04/2005
3Cholinergic Agents (Cholinergics)IBA
10/2011 - 05/2007
3N-Methylaspartate (NMDA)IBA
10/2011 - 04/2005
3Scopolamine (Hyoscine)FDA Link
10/2011 - 05/2007
3Nootropic Agents (Nootropics)IBA
08/2011 - 03/2009
3CytokinesIBA
01/2011 - 09/2003
3Dizocilpine Maleate (Dizocilpine)IBA
10/2010 - 03/2009
3Muscarinic AntagonistsIBA
12/2009 - 05/2007
2CannabinoidsIBA
07/2013 - 05/2011
2Dopamine (Intropin)FDA LinkGeneric
06/2010 - 10/2003
2Glycine (Aminoacetic Acid)FDA LinkGeneric
01/2009 - 04/2005
1Polytetrafluoroethylene (Teflon)FDA Link
01/2020
1Biomarkers (Surrogate Marker)IBA
01/2020
1Double-Stranded RNA (RNA, Double Stranded)IBA
01/2016
1Gonadal HormonesIBA
02/2012
1Risperidone (Risperdal Consta)FDA LinkGeneric
11/2011
1Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
10/2011
1xanomelineIBA
10/2011
1ProlactinIBA
05/2011
1AVE1625IBA
05/2011
1CB1 Cannabinoid Receptor (CB1 Receptor)IBA
05/2011
1Interleukin-8 (Interleukin 8)IBA
01/2011
1Estradiol (Delestrogen)FDA LinkGeneric
06/2010
1Neuroprotective AgentsIBA
11/2009
1SSR180711IBA
06/2009
1Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
06/2009
1Nitroarginine (NG Nitro L Arginine)IBA
06/2009
12- chloro- N- ((S)- phenyl((2S)- piperidin- 2- yl)methyl)- 3- trifluoromethyl benzamideIBA
01/2009
1Hormones (Hormone)IBA
11/2008
1Serine (L-Serine)FDA Link
04/2005
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
04/2005
1(R)- (N- (3- (4'- fluorophenyl)- 3- (4'- phenylphenoxy)propyl))sarcosineIBA
04/2005
1Quinolinic AcidIBA
12/2003

Therapy/Procedure

2Deep Brain Stimulation
01/2016 - 07/2013
2Drug Therapy (Chemotherapy)
03/2012 - 10/2011
2Ovariectomy (Oophorectomy)
02/2012 - 06/2010
1Transplantation
01/2018
1Behavior Control
10/2010